Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Advances in human immunodeficiency virus therapeutics
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Advances in human immunodeficiency virus therapeutics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Proteinase Inhibitor
50%
Tolerability
25%
Adverse Event
25%
Human Immunodeficiency Virus Infection
25%
Emtricitabine
25%
Zidovudine
25%
Lamivudine
25%
Tenofovir
25%
Chemokine Receptor CXCR4
25%
Chemokine Receptor CCR5
25%
Tipranavir
25%
Pharmacokinetics
25%
Nucleoside Analog
25%
Keyphrases
Approved Products
50%